News

Bengals Depth Chart Preview: Ted Karras centers the offensive line with possible competition brewing behind him originally appeared on A to Z Sports.
Acquired resistance to osimertinib (OSI) poses a significant challenge in the treatment of epidermal growth factor receptor mutant non-small cell lung cancer (NSCLC). Although OSI is effective as a ...
Bitcoin price starts ‘normal and healthy’ support test as $108K halts bulls BTC price returns to retest recently reclaimed levels as Bitcoin analysis flags the 50-day moving average trend line ...
Investors might not consider Delta Air Lines (NYSE: DAL) stock expensive due to its low price-to-earnings ratio of just over 8 times earnings. Still, some of them do stress over Delta's adjusted ...
We present a novel method for in-line acoustofluidic separation of cancer cells directly from whole blood. We report for the first time the observation that blood cells can self-organize when packed ...
CAR-T cells are specialized immune cells genetically modified to recognize and attack cancer cells. Researchers at Nagoya University in Japan and their collaborators have developed new CAR-T cells ...
imageimagePathway-focused metabolite ratio-based analysis of 49 tumor and 8 normal epithelial cell lines grown in their respective standard conditions reveals common and distinctive metabolic ...
Significance Bispecific T cell engagers (TcEs) are immunotherapeutic drugs that trigger the destruction of cancer cells by linking T cells to cancer cells through specific surface molecules (antigens) ...
The G train is next in line to expand connectivity this fall. The MTA confirmed during a committee meeting on May 28th that underground cell service is coming.
Normal liver function tests can occur when the liver has severe scarring, but the body is still able to compensate for its decreased function.
It’s been nine days since Kettering Health Network was hit with a ransomware cyberattack.
Phase 3 study of benmelstobart in combination with chemotherapy followed by sequential combination with anlotinib for the first-line treatment of locally advanced or metastatic squamous non-small cell ...